Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-158,772
Closed -$9.71M 248
2017
Q2
$9.71M Sell
158,772
-72,417
-31% -$4.41M 0.14% 186
2017
Q1
$14M Sell
231,189
-140,048
-38% -$8.5M 0.18% 159
2016
Q4
$20.9M Buy
371,237
+115,211
+45% +$6.74M 0.25% 122
2016
Q3
$15.2M Sell
256,026
-281,038
-52% -$16.4M 0.19% 155
2016
Q2
$29.5M Sell
537,064
-299,833
-36% -$16M 0.37% 81
2016
Q1
$42.3M Buy
836,897
+114,143
+16% +$5.59M 0.51% 61
2015
Q4
$36.4M Buy
722,754
+10,227
+1% +$516K 0.41% 79
2015
Q3
$33.6M Sell
712,527
-165,450
-19% -$8.79M 0.39% 85
2015
Q2
$47.7M Buy
877,977
+77,958
+10% +$4.37M 0.52% 60
2015
Q1
$43.9M Sell
800,019
-84,238
-10% -$4.77M 0.49% 60
2014
Q4
$47.9M Buy
884,257
+368,893
+72% +$20.6M 0.47% 73
2014
Q3
$29.2M Buy
515,364
+670
+0.1% +$37.6K 0.31% 105
2014
Q2
$28.4M Buy
514,694
+70,384
+16% +$3.84M 0.31% 107
2014
Q1
$24.1M Sell
444,310
-426,237
-49% -$22.1M 0.28% 123
2013
Q4
$41.6M Buy
+870,547
New +$39.8M 0.47% 71

Other funds holding MRK

Carlson Capital's MRK Position: Q3 2017 in Review

Carlson Capital sold out of Merck (MRK) in Q3 2017, closing a stake of 158,772 shares — an estimated $9.71M sold.

Carlson Capital first reported a position in MRK in Q4 2013 and held it in 15 quarters. The position peaked at $47.9M in Q4 2014. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Carlson Capital reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Carlson Capital sold 158,772 Merck shares in Q3 2017, an estimated $9.71M.
  • Carlson Capital first reported a position in Merck in Q4 2013 and held it in 15 quarters.
  • Carlson Capital's Merck position peaked at $47.9M in Q4 2014.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Carlson Capital's 13F filing for Q3 2017, filed 14 Nov 2017.